2-碘-N-(2-甲基苯基)乙酰胺 | 73663-82-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-碘-N-(2-甲基苯基)乙酰胺
• 英文名称: 2'-Methyl-2-iodoacetanilide
• 英文别名: 2-iodo-N-(o-methylphenyl)acetamide；iodo-acetic acid o-toluidide；Jodacet-o-toluidid；Jod-essigsaeure-o-toluidid；N-(Iodoacetyl)-2-toluidine；o-ACETOTOLUIDIDE, 2-IODO-；2-iodo-N-(2-methylphenyl)acetamide
• CAS: 73663-82-8
• 化学式: C₉H₁₀INO
• 分子量: 275.089
• InChiKey: PELYSUXCWVOHPG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-碘-N-(2-甲基苯基)乙酰胺 在 盐酸 、 sodium hydroxide 、 sodium ethanolate 作用下， 以 甲醇 、 乙醇 为溶剂， 反应 18.0h， 生成 1-(2-methylphenyl)-4-oxidopyrazin-4-ium-2-one
  参考文献：
  名称：

  Anticoccidials. IV. A convenient synthesis of 2(1H)-pyrazinone 4-oxide derivatives.

  摘要：

  2(1H)-吡嗪酮4-氧化物（emimycin）及其1-和6-取代衍生物，是通过不同的2-(羟胺基)乙酰胺与乙二醛反应合成的。

  DOI：

  10.1248/cpb.28.2720
• 作为产物：
  描述：

  2-氯-N-(2-甲基苯基)乙酰胺 在 potassium iodide 作用下， 以 丙酮 为溶剂， 反应 2.0h， 以91.2%的产率得到2-碘-N-(2-甲基苯基)乙酰胺
  参考文献：
  名称：

  设计和合成新型4'-demethyl-4-deoxypodophyllotoxin衍生物作为潜在的抗癌药。

  摘要：

  通过将芳氧基乙酰苯胺部分与4'-demethyl-4-deoxypodophyllotoxin（DDPT）的4'-羟基缀合，合成了一组鬼臼毒素（PPT）衍生物（7a-j），并评估了它们的抗癌活性。发现最有效的化合物7d以微摩尔IC 50值低抑制了三种癌细胞系的增殖。此外，已证明7d诱导MGC-803细胞中G2 / M期的细胞周期停滞，并调节细胞周期检查点蛋白如细胞周期蛋白A，细胞周期蛋白B，CDK1，cdc25c和p21的表达。最后，4 mg / kg的7d减少了小鼠HepG2异种移植的重量和体积。我们的发现表明7d可能是一种潜在的抗癌药。

  DOI：

  10.1016/j.bmcl.2015.06.089

文献信息

• Pyrimidine-2-sulphides and their S-oxides for use in medicine and
  申请人：Nyegaard & Co. A/S

  公开号：US04423047A1

  公开（公告）日：1983-12-27

  Compounds of the formula ##STR1## (wherein X represents a halogen atom; n is 0, 1 or 2; R.sup.1 and R.sup.2, which may be the same or different, each represents a hydrogen atom or a carboxyl, esterified carboxyl, amido or mono- or di-C.sub.1-4 alkylamido group or a C.sub.1-4 alkyl group which may if desired carry a carboxyl or esterified carboxyl group; and R.sup.3 represents a C.sub.1-32 saturated or unsaturated, straight or branched, cyclic or acyclic aliphatic group or an araliphatic or heterocyclic substituted aliphatic group, a heterocyclic group or an aryl group which groups may if desired carry one or more substituents selected from halogen atoms and oxo, nitro, hydroxy, etherified hydroxy, esterified hydroxy, primary, secondary or tertiary amino, acylamino etherified mercapto or S.dbd.O or --SO.sub.2 derivatives thereof and esterified phosphonic acid groups) and, where an acidic or basic group is present, physiologically compatible salts thereof have been found to be of use in combating abnormal cell proliferation. The compounds are prepared inter alia by oxidation of the corresponding sulfide, displacement of a leaving atom or group from the 2-position of the pyrimidine by reaction with a sulfinic acid or by ring closure of the pyrimidine ring.

  式##STR1##中的化合物（其中X代表卤素原子；n为0、1或2；R.sup.1和R.sup.2，可以相同也可以不同，每个代表氢原子或羧基、酯化羧基、酰胺基或单或双-C.sub.1-4烷基酰胺基或C.sub.1-4烷基基团，如果需要，可以带有羧基或酯化羧基团；R.sup.3代表C.sub.1-32饱和或不饱和、直链或支链、环状或非环状脂肪族基团或芳基脂肪族基团、芳基脂肪族基团、杂环取代脂肪族基团、杂环基团或芳基基团，这些基团如果需要，可以带有一个或多个卤素原子和氧代、硝基、羟基、醚化羟基、酯化羟基、一级、二级或三级氨基、酰胺基、醚化巯基或S.dbd.O或--SO.sub.2衍生物和酯化膦酸基团的取代基）以及存在酸性或碱性基团时，其生理相容盐已被发现可用于对抗异常细胞增殖。这些化合物可通过氧化相应的硫醚、通过与亚砜酸反应从嘧啶的2位处置换一个离去原子或基团，或通过嘧啶环的环闭合制备。
• New substituted 2-(pyrazol-1-yl) o-, m-, p-methylacetanilides with potential local anaesthetic and antiarrhythmic action. Part I
  作者：Mircea Iovu、Christina Zalaru、Florea Dumitrascu、Constantin Draghici、Elena Cristea

  DOI：10.1016/s0014-827x(00)00052-5

  日期：2000.5

  Fifteen substituted 2-(pyrazol-1-yl)acetanilides were synthesized by N-alkylation of pyrazole and some of its derivatives with several 2-iodoacetanilides. The new compounds exhibited local anaesthetic and antiarrhythmic actions. The new compounds have been characterized by elemental chemical analysis, UV-Vis, IR, 1H, 13C NMR spectra and pharmacology research.

  通过吡唑及其一些衍生物与几种2-碘乙酰苯胺的N-烷基化反应，合成了十五个取代的2-（吡唑-1-基）乙酰苯胺。新化合物表现出局部麻醉和抗心律不齐的作用。这些新化合物已通过元素化学分析，UV-Vis，IR，1H，13C NMR光谱和药理研究进行了表征。
• NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS
  申请人：Girardet Jean-Luc

  公开号：US20080249131A1

  公开（公告）日：2008-10-09

  Various carbonyl amides are employed in vitro and in vivo as non-nucleoside inhibitors of a reverse transcriptase, and particularly of HIV reverse transcriptase. Therefore, contemplated compounds may be employed in the treatment of HIV infected patients. Further contemplated aspects include pharmaceutical compositions comprising therapeutically effective amounts of contemplated compounds.

  各种羰基酰胺在体外和体内被用作反转录酶的非核苷类抑制剂，尤其是HIV反转录酶的抑制剂。因此，考虑到的化合物可以用于治疗HIV感染患者。进一步考虑的方面包括包含考虑化合物的治疗有效量的制药组合物。
• Pyrimidine-2-sulphides and their S-oxides for use in medicine, pharmaceutical compositions containing them, processes for their preparation and such compounds when novel per se
  申请人：NYEGAARD & CO. A/S

  公开号：EP0033195A1

  公开（公告）日：1981-08-05

  Compounds of the formula (wherein X represents a halogen atom; nis 0,1 or 2; R1 and R2, which may be the same or different, each represents a hydrogen atom or a carboxyl, esterified carboxyl, amido or mono-or di-C1-4 alkylamido group or a C1-4 alkyl group which may if desired carry a carboxyl or esterified carboxyl group; and R3 represents a Ci-32 saturated or unsaturated, straight or branched, cyclic or acyclic aliphatic group or an araliphatic or heterocyclic substituted aliphatic group, a heterocyclic group or an aryl group which groups may if desired carry one or more substituents selected from halogen atoms and oxo, nitro, hydroxy, etherified hydroxy, esterified hydroxy, primary, secondary or tertiary amino, acylamino etherified mercapto or S = 0 or -SO2 derivatives thereof and esterified phosphoric acid groups) and, where an acidic or basic group is present, physiologically compatible salts thereof have been found to be of use in combating abnormal cell proliferation. The compounds are prepared inter alia by oxidation of the corresponding sulfide, displacement of a leaving atom or group from the 2-position of the pyrimidine by reaction with a sulfinic acid or by ring closure of the pyrimidine ring.

  式中化合物 (其中 X 代表卤素原子；n 为 0、1 或 2；R1 和 R2（可以相同或不同）各自代表氢原子或羧基、酯化羧基、氨基或单或双-C1-4 烷基氨基或 C1-4 烷基（如需要可带羧基或酯化羧基）；在存在酸性或碱性基团的情况下，其生理相容性盐类可用于抑制异常细胞增殖。这些化合物的制备方法包括相应硫化物的氧化、通过与亚硫酸反应将嘧啶 2 位上的离去原子或基团置换或嘧啶环的闭环。
• Dumitraşcu, Florea; Mitan, Carmen Irena; Draghici, Constantin, Revue Roumaine de Chimie, 2002, vol. 47, # 3-4, p. 309 - 314
  作者：Dumitraşcu, Florea、Mitan, Carmen Irena、Draghici, Constantin、Cǎproiu, Miron Teodor、Cǎprǎu, Delia、Dumitrescu, Denisa

  DOI：——

  日期：——